What intramuscular vitamin B12 (hydroxocobalamin or cyanocobalamin) dose and schedule should be given to an adult with serum vitamin B12 of 183 pg/mL indicating deficiency?

Vitamin B12 Injection Dose for Deficiency

For an adult with vitamin B12 deficiency (183 pg/mL), administer hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks, followed by lifelong maintenance therapy with 1 mg intramuscularly every 2-3 months 1.

Critical First Step: Assess for Neurological Involvement

Before initiating treatment, you must determine whether neurological symptoms are present, as this fundamentally changes the dosing regimen:

Screen for these specific neurological symptoms:

• Unexplained sensory disturbances (paresthesias, numbness)
• Motor symptoms (weakness, gait disturbance)
• Cognitive impairment or psychiatric changes
• Signs of subacute combined degeneration of the spinal cord

If ANY neurological involvement is present or suspected:

• Seek urgent specialist advice from neurology and hematology immediately 1
• Administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further clinical improvement occurs 1
• Then transition to maintenance: 1 mg intramuscularly every 2 months 1

Standard Treatment Protocol (No Neurological Symptoms)

Since your patient has a B12 level of 183 pg/mL indicating deficiency without mention of neurological symptoms:

Loading Phase (First 2 Weeks)

• Hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks 1
• This provides 6 total injections during the loading phase

Maintenance Phase (Lifelong)

• Hydroxocobalamin 1 mg intramuscularly every 2-3 months for life 1
• The FDA label supports 100-200 mcg monthly as an alternative, but guideline recommendations favor the 1 mg every 2-3 months regimen 2

Important Clinical Considerations

Hydroxocobalamin vs. Cyanocobalamin: The guidelines specifically recommend hydroxocobalamin over cyanocobalamin 1. Recent research shows hydroxocobalamin has six-fold faster intracellular processing and two-fold faster cellular accumulation, suggesting earlier clinical response 3.

Critical Safety Warning - Folic Acid: Never administer folic acid before treating B12 deficiency 1. Folic acid can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord, causing irreversible neurological damage.

Monitor Potassium: Closely observe serum potassium during the first 48 hours of treatment and supplement if necessary 2. Rapid hematologic response can cause hypokalemia.

Expected Response Timeline:

• Biochemical markers (homocysteine, methylmalonic acid) improve within 1 day 4
• Reticulocytosis typically occurs between days 3-10 2
• Hematological parameters (MCV) normalize after 14 days 4
• All patients should achieve normal cobalamin levels by day 15 5

Common Pitfalls to Avoid

1. Inadequate loading dose frequency: Three times weekly for 2 weeks is essential—don't reduce this to weekly dosing
2. Premature discontinuation: Maintenance therapy must continue for life in malabsorption cases
3. Using oral therapy inappropriately: Oral B12 is unreliable in malabsorption and should not be used as primary treatment 2
4. Insufficient maintenance dosing: Some patients require individualized injection frequency (every 2-4 weeks) to remain symptom-free, though standard guidelines recommend every 2-3 months 6

Alternative Considerations

While the FDA label mentions 30 mcg daily for 5-10 days followed by 100-200 mcg monthly 2, the most recent 2020 guideline evidence strongly supports the 1 mg three times weekly regimen 1. The higher dose ensures adequate tissue saturation and is equally safe with no toxicity concerns.